Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Can J Microbiol ; 66(2): 99-110, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-31661630

RESUMO

This study examined the phylogenetic structure of serotype a Haemophilus influenzae (Hia) isolates recovered from patients in Canada. Hia isolates from 490 separate patients and an American Type Culture Collection (ATCC) strain were analyzed by multilocus sequence typing (MLST), with 18 different sequence types (STs) identified. Most (85.7%) Hia patient isolates were typed as ST-23 and another 12.7% belonged to 14 different STs with 6, 5, or 4 MLST gene loci related to ST-23 (ST-23 complex). Core genome single-nucleotide variation phylogeny (SNVPhyl) on whole genome sequence (WGS) data of 121 Hia patient isolates representing all identified STs and the ATCC strain revealed 2 phylogenetic populations, with all the ST-23 complex isolates within 1 population. The other phylogenetic population contained only the ATCC strain and 3 patient isolates. Concatenated hitABC sequences retrieved from WGS data and analyzed by MEGA (Molecular Evolutionary Genetic Analysis) alignment confirmed the phylogeny obtained by SNVPhyl. The sodC gene was found only in isolates in the minor phylogenetic population. The 2 phylogenetic populations of the Canadian Hia isolates are similar to the 2 clonal divisions described for serotype b H. influenzae. Combining MLST, core SNVPhyl, and hitABC gene sequence alignment showed that most (99.4%) Canadian Hia patient isolates belonged to 1 major phylogenetic population.


Assuntos
Infecções por Haemophilus/virologia , Haemophilus influenzae/genética , Sequenciamento Completo do Genoma , Canadá/epidemiologia , Pré-Escolar , Evolução Molecular , Feminino , Infecções por Haemophilus/epidemiologia , Haemophilus influenzae/imunologia , Humanos , Lactente , Masculino , Tipagem de Sequências Multilocus , Filogenia , Alinhamento de Sequência , Sorogrupo
2.
Clin Infect Dis ; 68(4): 680-683, 2019 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-30212859

RESUMO

Cestodes are emerging agents of severe opportunistic infections among immunocompromised patients. We describe the first case of human infection, with the recently-proposed genus Versteria causing an invasive, tumor-like hepatic infection with regional and distant extension in a 53-year-old female kidney transplant recipient from Atlantic Canada.


Assuntos
Cestoides/isolamento & purificação , Infecções por Cestoides/diagnóstico , Infecções por Cestoides/patologia , Transplante de Rim , Hepatopatias Parasitárias/diagnóstico , Hepatopatias Parasitárias/patologia , Transplantados , Animais , Canadá , Feminino , Humanos , Hospedeiro Imunocomprometido , Pessoa de Meia-Idade
3.
Can J Infect Dis Med Microbiol ; 2016: 7231805, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27478446

RESUMO

An 88-year-old man was admitted to the hospital with worsening malaise, fever, and weakness. Anaerobic blood culture bottles revealed the presence of an anaerobic, Gram-positive sporulated bacillus. Empirical antibiotherapy with intravenous piperacillin-tazobactam was initiated. The patient defervesced after four days and was switched to oral amoxicillin on his 6th day of antibiotic therapy and later discharged from the hospital. Four months later, he had recovered. The bacterium was initially identified as Clostridium butyricum using anaerobic manual identification panel. 16S rRNA gene sequence and phylogenetic analysis showed the bacterium to be Clostridium lavalense, a recently described species with no previously published case of isolation in human diagnostic samples so far. This is the first report of Clostridium lavalense isolation from human blood cultures. Further studies are needed in order to elucidate the role of Clostridium lavalense in human disease and its virulence factors.

4.
J Clin Microbiol ; 53(1): 191-200, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25378573

RESUMO

A large-scale, whole-genome comparison of Canadian Neisseria gonorrhoeae isolates with high-level cephalosporin MICs was used to demonstrate a genomic epidemiology approach to investigate strain relatedness and dynamics. Although current typing methods have been very successful in tracing short-chain transmission of gonorrheal disease, investigating the temporal evolutionary relationships and geographical dissemination of highly clonal lineages requires enhanced resolution only available through whole-genome sequencing (WGS). Phylogenomic cluster analysis grouped 169 Canadian strains into 12 distinct clades. While some N. gonorrhoeae multiantigen sequence types (NG-MAST) agreed with specific phylogenomic clades or subclades, other sequence types (ST) and closely related groups of ST were widely distributed among clades. Decreased susceptibility to extended-spectrum cephalosporins (ESC-DS) emerged among a group of diverse strains in Canada during the 1990s with a variety of nonmosaic penA alleles, followed in 2000/2001 with the penA mosaic X allele and then in 2007 with ST1407 strains with the penA mosaic XXXIV allele. Five genetically distinct ESC-DS lineages were associated with penA mosaic X, XXXV, and XXXIV alleles and nonmosaic XII and XIII alleles. ESC-DS with coresistance to azithromycin was observed in 5 strains with 23S rRNA C2599T or A2143G mutations. As the costs associated with WGS decline and analysis tools are streamlined, WGS can provide a more thorough understanding of strain dynamics, facilitate epidemiological studies to better resolve social networks, and improve surveillance to optimize treatment for gonorrheal infections.


Assuntos
Resistência às Cefalosporinas , Genoma Bacteriano , Gonorreia/epidemiologia , Gonorreia/microbiologia , Neisseria gonorrhoeae/efeitos dos fármacos , Neisseria gonorrhoeae/genética , Filogenia , Adolescente , Adulto , Antibacterianos/farmacologia , Canadá/epidemiologia , Criança , Pré-Escolar , Feminino , Genótipo , Gonorreia/história , História do Século XX , História do Século XXI , Humanos , Lactente , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Tipagem de Sequências Multilocus , Neisseria gonorrhoeae/classificação , Polimorfismo de Nucleotídeo Único , Adulto Jovem
5.
J Clin Microbiol ; 53(5): 1748-51, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25740765

RESUMO

The recent emergence of a severe respiratory disease caused by enterovirus D68 prompted investigation into whether Canadian hospital and provincial laboratories can detect this virus using commercial and laboratory-developed assays. This study demonstrated analytical sensitivity differences between commercial and laboratory-developed assays for the detection of enterovirus D68.


Assuntos
Técnicas de Laboratório Clínico/métodos , Testes Diagnósticos de Rotina/métodos , Enterovirus Humano D/isolamento & purificação , Infecções por Enterovirus/diagnóstico , Ensaio de Proficiência Laboratorial , Infecções Respiratórias/diagnóstico , Canadá , Infecções por Enterovirus/virologia , Humanos , Infecções Respiratórias/virologia , Sensibilidade e Especificidade
6.
Can J Infect Dis Med Microbiol ; 26 Suppl A: 18A-22A, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25798161

RESUMO

Neurosyphilis refers to infection of the central nervous system by Treponema pallidum, which may occur at any stage. Neurosyphilis has been categorized in many ways including early and late, asymptomatic versus symptomatic and infectious versus non-infectious. Late neurosyphilis primarily affects the central nervous system parenchyma, and occurs beyond early latent syphilis, years to decades after the initial infection. Associated clinical syndromes include general paresis, tabes dorsalis, vision loss, hearing loss and psychiatric manifestations. Unique algorithms are recommended for HIV-infected and HIV-uninfected patients, as immunocompromised patients may present with serologic and cerebrospinal fluid findings that are different from immunocompetent hosts. Antibody assays include a VDRL assay and the FTA-Abs, while polymerase chain reaction for T. pallidum can be used as direct detection assays for some specimens. This chapter reviews guidelines for specimen types and sample collection, and identifies two possible algorithms for use with immunocompromised and immunocompetent hosts using currently available tests in Canada, along with a review of treatment response and laboratory testing follow-up.


La neurosyphilis désigne l'infection du système nerveux central par le Treponema pallidum à tout stade de la maladie. Elle est classée de diverses façons, y compris précoce ou tardive, asymptomatique ou symptomatique, infectieuse ou non infectieuse. La neurosyphilis tardive touche principalement le parenchyme du système nerveux central et se manifeste après une syphilis latente précoce, des années ou même des décennies après l'infection initiale. Des syndromes cliniques s'y associent, y compris la parésie générale, le tabes dorsalis, la perte d'acuité visuelle et auditive et les manifestations psychiatriques. Des algorithmes différents sont recommandés pour les patients infectés ou non infectés par le VIH, car les manifestations sérologiques et céphalorachidiennes des patients immunodéprimés peuvent différer de celles des patients immunocompétents. Les tests de détection des anticorps incluent le VDRL et le FTA-Abs, tandis que pour certains prélèvements, la réaction en chaîne de la polymérase peut servir de test de détection du T. pallidum. Ce chapitre traite des directives sur les types de prélèvement et leur collecte et présente deux algorithmes qui peuvent être utilisés auprès des hôtes immunodéprimés et immunocompétents à l'aide des tests offerts au Canada. Il contient également une analyse de la réponse thérapeutique et du suivi des tests de laboratoire.

7.
Emerg Infect Dis ; 19(1): 119-22, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23260201

RESUMO

We describe 3 culture-proven cases of adenovirus serotype 14 infection in New Brunswick, Canada, during the summer of 2011. Strains isolated from severely ill patients were closely related to strains of a genomic variant, adenovirus 14p1, circulating in the United States and Ireland. Physicians in Canada should be aware of this emerging adenovirus.


Assuntos
Infecções por Adenovirus Humanos/diagnóstico , Infecções por Adenovirus Humanos/virologia , Adenovírus Humanos/genética , RNA Viral/genética , Infecções por Adenovirus Humanos/patologia , Adenovírus Humanos/classificação , Adenovírus Humanos/isolamento & purificação , Idoso , Evolução Fatal , Feminino , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Novo Brunswick , Filogenia , RNA Viral/classificação , RNA Viral/isolamento & purificação , Sorotipagem
8.
Can J Microbiol ; 59(10): 671-8, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24102220

RESUMO

The monitoring of antimicrobial susceptibilities in Neisseria gonorrhoeae isolates and characterization of N. gonorrhoeae multiantigen sequence types (NG-MAST, ST) provide important surveillance data as resistance rates continue to rise. A total of 2970 N. gonorrhoeae isolates were collected by Canadian provincial public health laboratories in 2010, and 1233 were submitted to the National Microbiology Laboratory for testing. The NG-MAST and minimum inhibitory concentration (MIC) by agar dilution were determined for each isolate. Of the 2970 isolates, 25.1% were resistant to penicillin, 34.6% resistant to tetracycline, 31.5% resistant to erythromycin, 35.9% resistant to ciprofloxacin, and 1.2% resistant to azithromycin. Decreased susceptibility to cefixime (MIC ≥ 0.25 mg/L) and ceftriaxone (MIC ≥ 0.125 mg/L) was identified in 3.2% and 7.3% of the isolates, respectively. The most common STs found in Canada were ST1407 (13.3%), ST3150 (11.3%), and ST3158 (9.0%), with 249 different STs identified among the isolates. Within the ST1407 group, 19.5% and 43.3% isolates have decreased susceptibility to cefixime and ceftriaxone, respectively. ST1407, the most prevalent NG-MAST in Canada in 2010, has been associated with high-level ceftriaxone MICs and with cefixime treatment failure cases worldwide. Identification and monitoring of STs and corresponding antimicrobial resistance profiles may be useful in surveillance programs and be used to inform public health actions.


Assuntos
Antibacterianos/farmacologia , Farmacorresistência Bacteriana , Gonorreia/microbiologia , Neisseria gonorrhoeae/efeitos dos fármacos , Canadá/epidemiologia , Monitoramento Epidemiológico , Gonorreia/epidemiologia , Humanos , Testes de Sensibilidade Microbiana , Neisseria gonorrhoeae/genética , Neisseria gonorrhoeae/isolamento & purificação , Prevalência
9.
Can Commun Dis Rep ; 49(9): 388-397, 2023 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-38463902

RESUMO

Background: In Canada, gonorrhea is the second most prevalent bacterial sexually transmitted infection. The Gonococcal Antimicrobial Surveillance Programme (GASP - Canada), a passive surveillance system monitoring antimicrobial resistance in Neisseria gonorrhoeae in Canada since 1985, is the source for this summary of demographics, antimicrobial resistance and N. gonorrhoeae multi-antigen sequence typing (NG-MAST) of gonococcal isolates collected in Canada in 2021. Methods: Provincial and territorial public health laboratories submitted N. gonorrhoeae cultures and data to the National Microbiology Laboratory in Winnipeg as part of the surveillance system. The antimicrobial resistance and molecular type of each isolate received were determined. Results: In total, 3,439 N. gonorrhoeae cultures were received from laboratories across Canada in 2021, a 9.9% increase since 2020 (n=3,130). Decreased susceptibility to cefixime increased significantly (p<0.001) in 2021 (1.5%) compared to 2017 (0.6%). No significant change in decreased susceptibility to ceftriaxone was detected between 2017 and 2021 (0.6%) (p>0.001); however, one ceftriaxone-resistant isolate was identified. Azithromycin resistance decreased significantly (p<0.001) in 2021 (7.6%) compared to 2017 (11.7%); however, there was a significant increase (p<0.001) in the proportion of cultures with an azithromycin minimum inhibitory concentration of at least 1 mg/L (2017=22.2% to 2021=28.1%). In 2021, NG-MAST-19875 (15.3%) was the most prevalent sequence type in Canada; 20.3% of isolates with this sequence type were resistant to azithromycin. Conclusion: The spread of antimicrobial-resistant gonorrhea is a significant public health concern. The continued regional and national surveillance of antimicrobial resistance in N. gonorrhoeae is essential in ensuring effective treatment therapies are recommended.

10.
Artigo em Inglês | MEDLINE | ID: mdl-23450274

RESUMO

INTRODUCTION: Little is known about the role of herpes simplex virus (HSV) type 1 (HSV1) in the epidemiology of genital herpes in Canada. Data on herpes viral cultures for two consecutive years obtained from L'Hôpital Dr GL Dumont, which performs all the viral culture testing in New Brunswick, were reviewed. It was hypothesized that HSV1 was the main cause of genital herpes in New Brunswick. METHODS: Samples of genital origin sent to the laboratory for HSV culture testing between July 2006 and June 2008 were analyzed. Samples from an unspecified or a nongenital source were excluded from analysis. Multiple positive samples collected from the same patient were pooled into a single sample. RESULTS: HSV was isolated from 764 different patients. HSV1 was isolated in 62.6% of patients (male, 55%; female, 63.8%). HSV1 was isolated in 73.2% of patients 10 to 39 years of age and in 32% of patients ≥40 years of age. The difference in rates of HSV1 infection between the 10 to 39 years of age group and the ≥40 years of age group was statistically significant (P<0.001 [χ(2)]). In a similar Canadian study performed in Nova Scotia, HSV1 was recovered in 53.7% of positive cultures (male, 36.7%; female, 58.1%). The rates of HSV1 infection reported by this study and the present study were significantly different (P<0.001 [χ(2)] for male, P=0.012 for female). CONCLUSION: In New Brunswick, HSV1 is the dominant type of HSV isolated in samples collected from a genital site. Significant rate differences were demonstrated between the groups 10 to 39 years of age and ≥40 years of age. INTRODUCTION: Little is known about the role of herpes simplex virus (HSV) type 1 (HSV1) in the epidemiology of genital herpes in Canada. Data on herpes viral cultures for two consecutive years obtained from L'Hôpital Dr GL Dumont, which performs all the viral culture testing in New Brunswick, were reviewed. It was hypothesized that HSV1 was the main cause of genital herpes in New Brunswick. METHODS: Samples of genital origin sent to the laboratory for HSV culture testing between July 2006 and June 2008 were analyzed. Samples from an unspecified or a nongenital source were excluded from analysis. Multiple positive samples collected from the same patient were pooled into a single sample. RESULTS: HSV was isolated from 764 different patients. HSV1 was isolated in 62.6% of patients (male, 55%; female, 63.8%). HSV1 was isolated in 73.2% of patients 10 to 39 years of age and in 32% of patients ≥40 years of age. The difference in rates of HSV1 infection between the 10 to 39 years of age group and the ≥40 years of age group was statistically significant (P<0.001 [χ2]). In a similar Canadian study performed in Nova Scotia, HSV1 was recovered in 53.7% of positive cultures (male, 36.7%; female, 58.1%). The rates of HSV1 infection reported by this study and the present study were significantly different (P<0.001 [χ2] for male, P=0.012 for female). CONCLUSION: In New Brunswick, HSV1 is the dominant type of HSV isolated in samples collected from a genital site. Significant rate differences were demonstrated between the groups 10 to 39 years of age and ≥40 years of age.


INTRODUCTION: On ne sait pas grand-chose du rôle du virus de l'herpès simplex de type 1 (VHS1) dans l'épidémiologie de l'herpès génital au Canada. Les chercheurs ont analysé les données des cultures d'herpès viral obtenues pendant deux années consécutives à L'Hôpital Dr-Georges-L.-Dumont, où toutes les cultures virales sont effectuées au Nouveau-Brunswick. Ils ont postulé que le VHS1 était la principale cause d'herpès génital dans la province. MÉTHODOLOGIE: Les chercheurs ont analysé les prélèvements génitaux envoyés en laboratoire entre juillet 2006 et juin 2008, en vue de cultures du virus d'herpès simplex (VHS). Ils ont exclu de l'analyse les prélèvements tirés d'une source non précisée ou d'origine non génitale. Ils ont regroupé dans un seul échantillon les multiples échantillons positifs prélevés chez le même patient. RÉSULTATS: Le VHS a été isolé chez 764 patients, et le VHS1, chez 62,6 % des patients (55 % chez les hommes, et 63,8 % chez les femmes), soit 73,2 % des patients de dix à 39 ans et 32 % des patients de 40 ans et plus. La différence de taux d'infection par le VHS1 entre le groupe des dix à 39 ans et celui des 40 ans et plus était statistiquement significative (χ2, P<0,001). Dans une étude canadienne similaire menée en Nouvelle-Écosse, 53,7 % des cultures positives contenaient le VHS1 (36,7 % chez les hommes, 58,1 % chez les femmes). Le taux d'infection par le VHS1 déclaré dans cette étude et celui de la présente étude différaient de manière significative (χ2, P<0,001 chez les hommes, P=0,012 chez les femmes). CONCLUSION: Au Nouveau-Brunswick, le VHS1 est le principal type de VHS isolé dans des échantillons d'origine génitale. On a établi des différences de taux significatives entre le groupe des dix à 39 ans et celui des 40 ans et plus.

11.
J Med Microbiol ; 71(12)2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-36748536

RESUMO

Introduction. Invasive meningococcal disease (IMD) caused by Neisseria meningitidis may show temporal and geographical changes in both the epidemiology and the characteristics of the strains involved.Gap statement. A study that examined invasive N. meningitidis causing IMD in Atlantic Canada from 2009 to 2013 was published in 2014. Data from subsequent years have not been described.Aim. This study examined the molecular epidemiology of IMD in four Atlantic Provinces of Canada as well as potential serogroup B (MenB) vaccine coverage.Methods. Individual IMD case isolates recovered from 2014 to 2020 were analysed for serotype and serosubtype antigens as well as by whole-genome sequencing (WGS) for prediction of potential MenB vaccine coverage.Results. Of the 56 IMD isolates, 42, 8, 5 and 1 were MenB, serogroup Y, serogroup W (MenW) and serogroup C, respectively. Geographical differences in the distribution of MenB clones revealed concentration of sequence type (ST)-269 clonal complex (cc) and ST-60 cc in Newfoundland and Labrador, while ST-41/44 cc (particularly ST-154) was predominantly found in New Brunswick and Nova Scotia. Core genome multi-locus sequence typing (cgMLST) also separated the New Brunswick and Nova Scotia ST-154 isolates into two clusters, with differences in their nhba and penA alleles. Furthermore, cgMLST also separated the ST-269 cc isolates in Atlantic Canada into the ST-1611 and the ST-269/ST-8924 clusters, with the latter showing high similarity to the ST-269 that first emerged in the Province of Quebec. Genetic Meningococcal Antigen Typing System showed that 54.8 % of MenB were predicted to be covered by the MenB vaccine Bexsero, with a further 38.1 % potentially covered by virtue of the presence of genes that encoded factor H-binding protein variant 1 proteins. Meningococcal deduced vaccine antigen reactivity predicted from WGS data showed that 95.3 % of MenB were covered by Trumenba. Four cases of IMD due to MenW ST-11 cc were also identified, with the first case found in 2018.Conclusions. This study provided evidence concerning the dynamics of N. meningitidis strains causing IMD in Atlantic Canada, with both geographical and temporal differences found. MenB vaccine appeared to provide good coverage of MenB IMD, especially towards the predominant strain of ST-154.


Assuntos
Infecções Meningocócicas , Vacinas Meningocócicas , Neisseria meningitidis Sorogrupo B , Neisseria meningitidis , Humanos , Tipagem de Sequências Multilocus , Antígenos de Bactérias/genética , Infecções Meningocócicas/epidemiologia , Infecções Meningocócicas/prevenção & controle , Neisseria meningitidis/genética , Canadá/epidemiologia , Sorogrupo , Células Clonais , Neisseria meningitidis Sorogrupo B/genética
12.
Can Commun Dis Rep ; 48(11-12): 571-579, 2022 Nov 03.
Artigo em Inglês | MEDLINE | ID: mdl-38298531

RESUMO

Background: The Gonococcal Antimicrobial Surveillance Programme is a passive surveillance system that has monitored antimicrobial resistance in Neisseria gonorrhoeae in Canada since the 1980s. This article summarizes the demographics, antimicrobial resistances and NG-MAST (N. gonorrhoeae multiantigen sequence typing) for cultures collected in 2020. Methods: The National Microbiology Laboratory (NML) in Winnipeg received resistant N. gonorrhoeae cultures from provincial and territorial public health laboratories. Agar dilution was used to determine the minimum inhibitory concentrations to ten antimicrobials for all cultures received at NML, according to Clinical and Laboratory Standards Institute guidelines. The NG-MAST typing was also determined for each culture. Results: A total of 3,130 N. gonorrhoeae cases were cultured across Canada in 2020; a 36% decrease from 2019 (n=4,859). The level of decreased susceptibility to cefixime increased significantly between 2016 and 2020 to 2.8% (p=0.0054). Decreased susceptibility to ceftriaxone declined significantly between 2016 (1.8%) and 2020 to 0.9% (p=0.001), and there was no significant change with azithromycin between 2016 (7.2%) and 2020 (6.1%). The proportion of cultures with an azithromycin minimum inhibitory concentrations of ≥1 mg/L increased significantly from 11.6% in 2016 to 15.3% in 2020 (p=0.0017). The most common NG-MAST type in Canada for 2020 was sequence type (ST)-11461, while ST-12302 was most commonly associated with azithromycin resistance and ST-16639 with cephalosporin decreased susceptibility. Conclusion: Antimicrobial resistance in N. gonorrhoeae remains an important public health concern and continued surveillance is imperative to monitor trends to ensure the recommended therapies will be the most effective.

13.
Diagn Microbiol Infect Dis ; 101(3): 115412, 2021 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-34425450

RESUMO

The COVID-19 pandemic has led to the influx of immunoassays for the detection of antibodies towards severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the global market. The Canadian Public Health Laboratory Network Serology Task Force undertook a nationwide evaluation of twelve laboratory and 6 point-of-care based commercial serological assays for the detection of SARS-CoV-2 antibodies. We determined that there was considerable variability in the performance of individual tests and that an orthogonal testing algorithm should be prioritized to maximize the accuracy and comparability of results across the country. The manual enzyme immunoassays and point-of-care tests evaluated had lower specificity and increased coefficients of variation compared to automated enzyme immunoassays platforms putting into question their utility for large-scale sero-surveillance. Overall, the data presented here provide a comprehensive approach for applying accurate serological assays for longitudinal sero-surveillance and vaccine trials while informing Canadian public health policy.


Assuntos
Anticorpos Antivirais/sangue , COVID-19/epidemiologia , Laboratórios/normas , Saúde Pública , SARS-CoV-2/imunologia , Testes Sorológicos/normas , COVID-19/sangue , Canadá/epidemiologia , Ensaios de Triagem em Larga Escala , Humanos , Técnicas Imunoenzimáticas , SARS-CoV-2/isolamento & purificação , Testes Sorológicos/métodos
18.
Artigo em Inglês | MEDLINE | ID: mdl-22379488

RESUMO

Adenovirus is a commonly isolated virus in clinical samples. Life-threatening infections, although rare, are described worldwide. An epidemic spread of an adenovirus type 3 strain occurred in the province of New Brunswick during the fall of 2008 to the winter of 2009; it resulted in three severely ill patients, with one fatality. Adenovirus should be considered as a cause of severe community-acquired viral pneumonia, especially when the influenza test is negative.

19.
J Clin Microbiol ; 45(7): 2321-3, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17494719

RESUMO

Legionella jordanis was first described in 1982 after isolation from environmental sources and is otherwise a very rare human pathogen. Here, we report the recovery of L. jordanis from a bronchoalveolar lavage specimen from a patient who presented with an indolent lower respiratory tract infection associated with constitutional symptoms. This case is the first culture-positive case of infection involving this species in Canada.


Assuntos
Legionella/classificação , Legionelose/diagnóstico , Legionelose/microbiologia , Antibacterianos/uso terapêutico , Compostos Aza/uso terapêutico , Fluoroquinolonas , Humanos , Legionella/genética , Legionella/isolamento & purificação , Legionelose/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Moxifloxacina , Quinolinas/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA